DexCom faces challenges in 2024 due to competition and missteps, but the long-term outlook for continuous glucose monitors ...

In a report released today, Larry Biegelsen from Wells Fargo maintained a Buy rating on Dexcom (DXCM – Research Report), with a price target of ...

DexCom Inc (DXCM) stock saw a modest uptick, ending the day at $78.41 which represents a slight increase of $0.69 or 0.89% from the prior close of $77.72. The stock opened at $78.09 and touched a low ...

DexCom (NASDAQ:DXCM – Get Free Report) had its target price increased by stock analysts at Canaccord Genuity Group from $89.00 to $99.00 in a research report issued to clients and investors on Monday, ...

Citi raised the firm’s price target on DexCom (DXCM) to $91 from $85 and keeps a Buy rating on the shares as part of a 2025 outlook for the ...

DexCom Inc (DXCM) stock saw a decline, ending the day at $78.92 which represents a decrease of $-2.09 or -2.58% from the prior close of $81.01. The stock opened at $80.91 and touched a low of $78.06 ...

Unfortunately for shareholders, while the DexCom, Inc. (NASDAQ:DXCM) share price is up 56% in the last five years, that's less than the market return. Zooming in, the stock is actually down 34% in ...

In the assessment of 12-month price targets, analysts unveil insights for DexCom, presenting an average target of $98.44, a ...

If you buy and hold a stock for many years, you'd hope to be making a profit. But more than that, you probably want ...

The Nasdaq 100 Index is one of the most replicated indexes by mutual funds and various exchange traded funds (ETFs). Between ...

SAN DIEGO & SAN FRANCISCO, November 19, 2024--DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, and ŌURA, maker of the world’s leading smart ring, announced today a strategic ...